Cofrogliptin Once Every 2 Weeks as Add-on Therapy to Metformin and Dapagliflozin Versus Daily Linagliptin in Patients With Type 2 Diabetes.
Conditions
T2DM
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Wuhan University People's Hospital, Wuhan, Hubei, China
Contact: Principal Investigator (Xuefeng Yu, Doctor)Wuhan University People's Hospital, Wuhan, Hubei, China
Study leads
XueFeng Yu, Doctor
Principal Investigator
Tongji Hosptial Affiliated to Tongji Medical College of Huazhong University fo Science and Technology